Connect Biopharma Holdings Ltd ADR (CNTB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 698 | 1,219 | 0 | 0 | 0 |
| Gross Profit | 698 | 1,219 | N/A | N/A | N/A |
| Operating Expenses | 10,317 | 15,065 | 0 | 12,633 | 0 |
| Operating Income | -9,619 | -13,846 | N/A | -12,633 | N/A |
| Other Income | 819 | 1,027 | 0 | 3,970 | 0 |
| Pre-tax Income | -8,800 | -12,819 | 0 | -8,663 | 0 |
| Income Tax | 106 | 57 | N/A | 30 | N/A |
| Net Income Continuous | -8,906 | -12,876 | N/A | -8,693 | N/A |
| Net Income | $-8,906 | $-12,876 | $N/A | $-8,693 | $N/A |
| EPS Basic Total Ops | -0.16 | -0.23 | N/A | -0.16 | N/A |
| EPS Basic Continuous Ops | -0.16 | -0.23 | N/A | -0.16 | N/A |
| EPS Diluted Total Ops | -0.16 | -0.23 | N/A | -0.16 | N/A |
| EPS Diluted Continuous Ops | -0.16 | -0.23 | N/A | -0.16 | N/A |
| EBITDA(a) | $-9,461 | $-13,670 | $N/A | $-12,469 | $N/A |